Fact: In 1947, the FDA approved the use of DES to prevent adverse pregnancy outcomes in women with a history of miscarriage. Fact: In 1971, The FDA removed prevention of miscarriage as an indication for DES use and added pregnancy as a contraindication for DES use. Yes you read well "contraindication"! The FDA issued a warning but didn't ban DES! via Diethylstilbestrol, Journal of a DES Daughter
A breast cancer survivor, Jackie, reports on her DES journey. Jackie White is one of 53 women who is bringing the DES Breast Cancer lawsuit in Boston against the maker of the drug DES (diethylstilbestrol) prescribed to millions of women decades ago.
Routine mammograms: Should we or shouldn't we? This new study supports the idea that routine mammograms can prevent deaths from breast cancer without causing undue harm. DES daughters have a higher risk of developing breast cancer after age 40 ... #mammogram #breastcancer
In DES Daughters, Susan Bell recounts the experiences of this generation of "victims." In moving, heartfelt narratives, she presents the voices of those women who developed cancer, those who were cancer-free but have concerns about becoming pregnant, and those who suffered other medical and/or reproductive difficulties.
Researchers warn that endocrine disruptors can trigger hormonal changes in the body that may not show up for decades. One called DES, a synthetic form of estrogen, was once routinely given to pregnant women to prevent miscarriage or morning sickness, and it did little harm to the women themselves. But it turned out to cause vaginal cancer and breast cancer decades later in their daughters
DES Daughter? I never blamed my mother for what happened to me. Any blame to go around—and there was plenty—should have been distributed among the long parade of doctors who misdiagnosed me at every turn.